Immunity to murine prostatic tumors: continuous provision of T-cell help prevents CD8 T-cell tolerance and activates tumor-infiltrating dendritic cells.
about
Trafficking of high avidity HER-2/neu-specific T cells into HER-2/neu-expressing tumors after depletion of effector/memory-like regulatory T cellsDifferential requirement for CD70 and CD80/CD86 in dendritic cell-mediated activation of tumor-tolerized CD8 T cells.CD4+ T cells elicit host immune responses to MHC class II-negative ovarian cancer through CCL5 secretion and CD40-mediated licensing of dendritic cells.CD8+ T-cell responses rapidly select for antigen-negative tumor cells in the prostate.Whole-body irradiation increases the magnitude and persistence of adoptively transferred T cells associated with tumor regression in a mouse model of prostate cancerAntitumor effect of malaria parasite infection in a murine Lewis lung cancer model through induction of innate and adaptive immunity.Protective CD8 memory T cell responses to mouse melanoma are generated in the absence of CD4 T cell helpRebalancing immune specificity and function in cancer by T-cell receptor gene therapy.High-avidity T cells are preferentially tolerized in the tumor microenvironmentFOXO3 programs tumor-associated DCs to become tolerogenic in human and murine prostate cancer.Anti-CD27 Antibody Potentiates Antitumor Effect of Dendritic Cell-Based Vaccine in Prostate Cancer-Bearing Mice.Human renal cell carcinoma induces a dendritic cell subset that uses T-cell crosstalk for tumor-permissive milieu alterations.Alkylating agent melphalan augments the efficacy of adoptive immunotherapy using tumor-specific CD4+ T cellsPolyfunctional CD4⁺ T cells are essential for eradicating advanced B-cell lymphoma after chemotherapy.Isolation of immune cells from primary tumors.Adoptive transfer of cytotoxic T lymphocytes targeting two different antigens limits antigen loss and tumor escapeInflammatory genetic markers of prostate cancer risk.Stressful presentations: mild cold stress in laboratory mice influences phenotype of dendritic cells in naïve and tumor-bearing mice.TGF-beta signalling and immunity in prostate tumourigenesis.Enhancing adoptive immunotherapy of cancer.Immunotherapy-induced CD8+ T cells instigate immune suppression in the tumor.Immune suppression in the tumor microenvironment: a role for dendritic cell-mediated tolerization of T cells.Cytotoxic chemotherapy and CD4+ effector T cells: an emerging alliance for durable antitumor effects.Modulation of Immune Cell Functions by the E3 Ligase Cbl-b.Prospects for the use of ipilimumab in treating advanced prostate cancer.Nonblocking Monoclonal Antibody Targeting Soluble MIC Revamps Endogenous Innate and Adaptive Antitumor Responses and Eliminates Primary and Metastatic Tumors.Reinforcement of cancer immunotherapy by adoptive transfer of cblb-deficient CD8+ T cells combined with a DC vaccine.Phase I study of intraprostatic vaccine administration in men with locally recurrent or progressive prostate cancer.Enhanced antitumor effects of a dendritic cell vaccine transfected with gastric cancer cell total RNA carrying the 4-1BBL gene in vitro.FOXO3: A master switch for regulating tolerance and immunity in dendritic cellsPten loss in CD4 T cells enhances their helper function but does not lead to autoimmunity or lymphoma.Identification of promiscuous HPV16-derived T helper cell epitopes for therapeutic HPV vaccine design.Adjuvant IL-7 potentiates adoptive T cell therapy by amplifying and sustaining polyfunctional antitumor CD4+ T cellsCD4+ T-cell help in the tumor milieu is required for recruitment and cytolytic function of CD8+ T lymphocytesSpontaneous presence of FOXO3-specific T cells in cancer patients.Transfer of Allogeneic CD4+ T Cells Rescues CD8+ T Cells in Anti-PD-L1-Resistant Tumors Leading to Tumor Eradication.Steady-state antigen-expressing dendritic cells terminate CD4+ memory T-cell responses.Cancer immunotherapy based on mutation-specific CD4+ T cells in a patient with epithelial cancer
P2860
Q28732041-68DB04A5-D862-4A39-B98C-753BC8D04205Q33768093-E3F4E84E-D53E-4FE3-8E46-381D404AF039Q33867018-823525A4-826B-49EE-A511-3ED8EBEC260FQ33931006-38B2DD24-8ADE-4F40-8A59-A7C0FAFAAF97Q34016750-C6171B61-B7C3-4EE9-8A73-BA42772C0792Q34023502-363035DC-EA78-4A7E-ADCA-ECCEAFB51E15Q34064488-1E43CC0C-D082-4D09-A4E5-EA2F996641E5Q34084756-A932AF5A-738A-48C9-906A-57D0710AAD7FQ34463820-EC2593B6-630E-4227-A119-D0B3D1066282Q34755205-6C613A89-E489-4572-8F38-C9F813C00024Q34993204-0D8A3BC9-F4E5-4EBC-BC53-397F1FACC0AFQ35070193-0E464811-0EAA-43A5-9047-B64A89137524Q35071850-A2F54082-B09C-4446-AE59-18B43FD543BDQ36249440-33766C70-605D-440D-A060-A4BD22519F0CQ36317449-323FAA05-5DDF-4428-B04C-74DCD0236CEEQ36321054-B391B402-CCA1-480A-AA83-43A0E1062225Q37328413-7F2C614E-47B6-46EA-8360-9B36C1F13776Q37571842-E67D514E-FDC1-4991-B0DF-A7455A676CEFQ37670250-EF94EC35-BA07-4E48-943C-0D1C2382A96BQ37687429-E0D8439E-0942-4F83-84BE-422748E0C3F7Q37690444-420B3EA0-85A0-442D-808F-3938829746DFQ37975160-302353F7-65B6-4572-BA67-82852FCA1B2EQ37991701-E1EBC4AC-2AAF-46CB-B1B7-F6178CFD4CAFQ38393275-EA421885-C8E5-4DFF-8E48-AA1AFF4D72BFQ38677420-A369BAA5-BF1D-4DF9-A6FF-D1B9438E9846Q38860610-9820C0C3-52EF-49C2-B346-31FDE5003380Q39579695-296CADDC-C22B-4E66-AF15-54E9032E6409Q40241848-AED98B7C-FCDB-4DEE-9ACD-EF330FF4335FQ41903166-7F0C337B-1E2E-4F7F-88F4-E3853C7BAEACQ42204320-2E41028F-342D-4828-9504-B7283E5B9E0DQ42206056-72A5CF42-4226-4F4A-A639-D04A64BB4E95Q42218961-21DAE9D2-2849-4CF8-A8E0-D909B67463CCQ42362935-91CBA08F-28D2-4317-B146-46F293B59855Q42385826-D980FBC1-356E-4B0E-81A3-4E794C7077C1Q43196241-F1D0DA9C-C857-4706-B22B-BC1CC0298B27Q50957786-749BBEB7-CC14-441C-979E-2380D5588982Q51057483-209C3AB8-ED24-4706-ADFC-C69A209DADF4Q57152489-D32E2FB0-E97A-4A2C-96DF-39AF19EF67A7
P2860
Immunity to murine prostatic tumors: continuous provision of T-cell help prevents CD8 T-cell tolerance and activates tumor-infiltrating dendritic cells.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 21 July 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Immunity to murine prostatic t ...... -infiltrating dendritic cells.
@en
Immunity to murine prostatic t ...... -infiltrating dendritic cells.
@nl
type
label
Immunity to murine prostatic t ...... -infiltrating dendritic cells.
@en
Immunity to murine prostatic t ...... -infiltrating dendritic cells.
@nl
prefLabel
Immunity to murine prostatic t ...... -infiltrating dendritic cells.
@en
Immunity to murine prostatic t ...... -infiltrating dendritic cells.
@nl
P2093
P2860
P1433
P1476
Immunity to murine prostatic t ...... -infiltrating dendritic cells.
@en
P2093
Anatoli Malyguine
Arthur A Hurwitz
Kimberly A Shafer-Weaver
Lauren J Draper
Michael J Anderson
Norman M Greenberg
Stephanie K Watkins
W Gregory Alvord
P2860
P304
P356
10.1158/0008-5472.CAN-08-4516
P407
P577
2009-07-21T00:00:00Z